Affordable Biologics
We believe in constantly challenging the status quo in order to move toward more affordable biologics for everyone.
innovative Processes
We are currently developing innovative processes for purification and subcutaneous delivery of proteins especially monoclonal antibodies for early discovery to late stage preclinical products.
cutting - edge technologies
Our cutting-edge technologies and services, combine art and science in creating innovative biological formulations.
Welcome to
Bhami Research Laboratory
High Concentration Protein Formulation Technology
BRL has received a worldwide patent for its technology for High Concentration Protein Formulations with Reduced Viscosity, in May 2020. This technology holds the potential as a platform technology and enables SubQ delivery of mAbs, by combining low volume, high concentration formulation with an appropriate delivery device like a syringe, wearable device or an autoinjector.
Protein Purification using Crystallization Technology
The BRL proprietary platform for purification of proteins by crystallization is an efficient alternative to Protein A Column Chromatography. This platform requires minimum capex and is applicable for purification of proteins, peptides and enzymes. This is a quick, easily scalable and highly cost effective alternative to conventional purification. As biologic manufacture moves towards “Continuous Manufacturing”
Instead of investing in ‘me-too’ strategies, global pharma companies can adopt a differentiated and defensible strategy using BRL technologies
Our Management
more accessible and affordable for all.
Dr. Bhami Shenoy, PhD
Co-Founder &
Chief Science Office
Dr. Surya Pai, BDS
Co-founder &
CEO
Dr. Viren Sarin, PhD
Scientific Advisor
Retd. Distinguished Fellow, Eli Lilly
Financial Results 2020 - 21
Our cutting-edge technologies and services, combine art and science in creating
innovative biological formulations.
Articles
Researches
Satisfied
Members
Latest News
Subcutaneous Trastuzumab Case: Achieving concentration of 250mg/mL at a syringeable viscosity of 18 cP.
Using only 2 GRAS excipients, BRL has achieved concentrations of over 250mg/mL with viscosities less than 20cP. Stability data - both in-house...
Worldwide patent granted for “High Concentration Protein Formulations with Reduced Viscosity”.
With this new patented technology that holds great potential as a 'Platform' technology, BRL aims to help large and small biopharmaceutical...
Dr. Bhami Shenoy envisions a bright future for biologics in India.
With multiple patents, publications and grants under his belt, Dr. Bhami Shenoy is one of the foremost scientists in the field of protein...